C. G. Arman

发表

The Chemistry of the Non-Steroidal Antipyretic Agents: Structure-Activity Relationships

D. Kim, C. G. Arman, D. Armstrong, 1982 .

Role of prostaglandin endoperoxide PGG2 in inflammatory processes

R. Egan, E. A. Ham, F. Kuehl, 1977, Nature.

Biologically active derivatives of fatty acids

R. Egan, F. Kuehl, C. G. Arman, 1977, Inflammation.

Brief review of mechanisms in chronic inflammation

C. G. Arman, 1976, Agents and Actions.

Oedema and Increased Vascular Permeability

C. G. Arman, 1979 .

SOME DETAILS OF THE INFLAMMATIONS CAUSED BY YEAST AND CARRAGEENIN (WITH APPENDIX ON KINETICS OF THE REACTION)

C. G. Arman, Á. Bégány, L. Miller, 1965 .

Amino acids and amines as precursors of epinephrine.

C. G. Arman, 1951 .

Factors affecting epinephrine content of adrenal glands.

C. G. Arman, 1950 .

Identification of the biologically active form of sulindac.

C. G. Arman, D. E. Duggan, K. F. Hooke, 1977, The Journal of pharmacology and experimental therapeutics.

PROTEOLYTIC ENZYMES AS MEDIATORS OF PAIN

C. G. Arman, G. Nuss, C. Winter, 1968 .

The origin of bradykinin.

C. G. Arman, 1952 .

Role of the kallikrein-kinin system in inflammation

C. G. Arman, 1975 .

2-(SUBSTITUTED PHENYL)OXAZOLO(4,5-B)PYRIDINES AND 2-(SUBSTITUTED PHENYL)OXAZOLO(5,4-B)PYRIDINES AS NONACIDIC ANTIINFLAMMATORY AGENTS

C. G. Arman, T. Lanza, T. Shen, 1979 .

The two distinct phase of inflammatory response in the dog's knee joint

C. G. Arman, R. Carlson, 1969 .